Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitafloxacin vs levofloxacin in acute mild to moderate respiratory or urinary tract infections
CTR20130313Phase 2Active
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitafloxacin in acute bacterial respiratory infection (ABRI), Acute Bacterial Urinary Tract Infection (UTI). Started Sep 2013; status: active.
02
Drugs
sitafloxacin
03
Conditions
acute bacterial respiratory infection (ABRI)Acute Bacterial Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20130313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130313.